Interestingly, the IDO1 inhibitor lindrodostat had no inhibitory effects on LNCaP-EnzR or PC3 cells (Supplementary Fig. S13a), which was consistent with the finding that prostate cancer cells expressed undetectable levels of IDO1 protein (Fig. 3e). Here, IDO1 is linked to Familial prostate cancer.